Affymetrix Launches New OncoScan™ FFPE Assay Kit Breakthrough assay provides genome wide solid tumor copy number analysis in only 48 hours from only 80ng input DNA SANTA CLARA, Calif.--(BUSINESS ...

Well known for genomics solutions, Affymetrix shows off its new side: assays and reagents for protein and cell analysis. genprowebdirectory Facebook Linkedin RSS Twitter Youtube ...

Affymetrix to Acquire Panomics Proven Assay Products for Low to Mid-Plex Applications Will Strengthen Company's Position in High-Growth Validation and Routine-Testing Markets SANTA CLARA, ...

Affymetrix will sell the Luminex instruments together with ProcartaPlex ® multiplexed immunoassays and QuantiGene ® Plex multiplexed quantitative gene expression assays, offering complete ...

Contacts. Affymetrix Inc. Andrew Noble, 408-731-5571 (Media) Associate Director, Corporate Communications Doug Farrell, 408-731-5285 (Investors) Vice President, Investor Relations ...

Global genetic devices maker Affymetrix Inc. (AFFX) has launched a new product, OncoScan FFPE Assay Kit, a genome wide copy number assay for analyzing highly degraded Formalin-fixed, paraffin ...

Affymetrix has announced the extension of its QuantiGene® Singleplex Assay for PCR-free gene expression measurement to include a 384-well format that is easily automatable for high-throughput compound ...

Affymetrix and Cytox have agreed to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s disease (AD) and mild ...

The FDA has authorized for marketing the Affymetrix CytoScan Dx Assay, a diagnostic tool that can analyze an entire genome and detect large and small chromosomal changes based on a blood sample.

Affymetrix, Inc. (AFFX) Q4 2008 Earnings Call January 28, 2009 5:00 PM ETExecutivesDoug Farrell - VP, IRKevin King - President and CEOJohn Batty - CFO and ...